Adam Siebert & Jeff Holder: early investment in manufacturing is critical for CGT accessibility

Sdílet
Vložit
  • čas přidán 28. 08. 2024
  • In this episode of the Ori Spotlight Podcast, Jason C. Foster hosts Jeff Holder and Adam Siebert from LEK Consulting, offering an in-depth exploration of the evolving cell and gene therapy (CGT) industry.
    LEK Consulting, a global leader in strategic advisory, aims to address the critical challenges of scalability and commercial viability within the CGT sector. Jeff and Adam, with their extensive background in life sciences consulting, share their insights on the importance of early investment in manufacturing processes to ensure that groundbreaking therapies can be delivered to patients efficiently and on a large scale.
    Together they explore the intricacies of CGT production, the significance of early-stage manufacturing considerations, and their collective vision for making advanced therapies more accessible to those in need.

Komentáře •